Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
NCT07640191
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Drug Resistant Epilepsy
Interventions
DEVICE:
iVEAcare Neuromodulation System
Sponsor
iVEAcare